Literature DB >> 16949333

A comparative study on the antimutagenic properties of aqueous extracts of Aspalathus linearis (rooibos), different Cyclopia spp. (honeybush) and Camellia sinensis teas.

J D van der Merwe1, E Joubert, E S Richards, M Manley, P W Snijman, J L Marnewick, W C A Gelderblom.   

Abstract

Antimutagenic activity of aqueous extracts of the South African herbal teas, Aspalathus linearis (rooibos) and Cyclopia spp. (honeybush) was compared with that of Camellia sinensis (black, oolong and green) teas in the Salmonella mutagenicity assay using aflatoxin B(1) (AFB(1)) and 2-acetylaminofluorene (2-AAF) as mutagens. The present study presents the first investigation on antimutagenic properties of C. subternata, C. genistoides and C. sessiliflora. The herbal teas demonstrated protection against both mutagens in the presence of metabolic activation, with the exception of "unfermented" (green/unoxidised) C. genistoides against 2-AAF, which either protected or enhanced mutagenesis depending on the concentration. Antimutagenic activity of "fermented" (oxidised) rooibos was significantly (P<0.05) less than that of Camellia sinensis teas against AFB(1), while for 2-AAF it was less (P<0.05) than that of black tea and similar (P>0.05) to that of oolong and green teas. Antimutagenic activity of unfermented C. intermedia and C. subternata exhibited a similar protection as fermented rooibos against AFB(1). Against 2-AAF, fermented rooibos exhibited similar protective properties than unfermented C. intermedia and C. sessiliflora. Unfermented rooibos was less effective than the C. sinensis teas and fermented rooibos, but had similar (P>0.05) antimutagenicity to that of fermented C. sessiliflora against AFB(1) and fermented C. subternata against 2-AAF. Fermented C. intermedia and C. genistoides exhibited the lowest protective effect against 2-AAF, while fermented C. intermedia exhibited the lowest protection when utilising AFB(1) as mutagen. Aspalathin and mangiferin, major polyphenols in rooibos and Cyclopia spp., respectively, exhibited weak to moderate protective effects when compared to the major green tea catechin, (-)epigallocatechin gallate (EGCG). Antimutagenic activity of selected herbal tea phenolic compounds indicated that they contribute towards (i) observed antimutagenic activity of the aqueous extracts against both mutagens and (ii) enhancement of the mutagenicity of 2-AAF by unfermented C. genistoides. Antimutagenic activity of the South African herbal teas was mutagen-specific, affected by fermentation and plant material, presumably due to changes and variation in phenolic composition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949333     DOI: 10.1016/j.mrgentox.2006.06.030

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Effects of water solutions on extracting green tea leaves.

Authors:  Wen-Ying Huang; Yu-Ru Lin; Ruei-Fen Ho; Ho-Yen Liu; Yung-Sheng Lin
Journal:  ScientificWorldJournal       Date:  2013-08-07

2.  Effectiveness of the Novel Herbal Medicine, KIOM-MA, and Its Bioconversion Product, KIOM-MA128, on the Treatment of Atopic Dermatitis.

Authors:  Tae Ho Chung; Tae Jin Kang; Won-Kyung Cho; Ga Young Im; Geum Seon Lee; Min Cheol Yang; Chang-Won Cho; Jin Yeul Ma
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-01       Impact factor: 2.629

3.  Divide and Conquer May Not Be the Optimal Approach to Retain the Desirable Estrogenic Attributes of the Cyclopia Nutraceutical Extract, SM6Met.

Authors:  M Mortimer; K Visser; D de Beer; E Joubert; A Louw
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.

Authors:  Omolola R Oyenihi; Annadie Krygsman; Nicolette Verhoog; Dalene de Beer; Michael J Saayman; Thys M Mouton; Ann Louw
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

5.  The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.

Authors:  Siyabulela S B N Ntuli; Wentzel C A Gelderblom; David R Katerere
Journal:  BMC Complement Altern Med       Date:  2018-03-15       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.